Methocarbamol

Product NDC: 10135-664
11-digit product format: 101350664
Labeler code: 10135
Product ID: 10135-664_d258986c-63ef-465b-e053-2995a90a8005
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Methocarbamol
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Marlex Pharmaceuticals Inc
Application: ANDA208507
Marketing category: ANDA
Marketing start: 2018-10-01
Marketing end: 0000-00-00
Substance: METHOCARBAMOL
Active strength: 500 mg/1
Pharmacologic classes: Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	10135-664		I	Inactivated by FDA	2026-08-10
excluded package	package	10135-664	10135-664-01	I	Inactivated by FDA	2026-08-10
excluded package	package	10135-664	10135-664-05	I	Inactivated by FDA	2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 45 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10135-664-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10135-664-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10135-664-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10135-664-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10135-664-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10135-664-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10135-664-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10135-664-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10135-664-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10135-664-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10135-664-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10135-664-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10135-664-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10135-664-05	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10135-664-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10135-664-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10135-664-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10135-664-05	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	10135-664-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	10135-664-05	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	10135-664-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	10135-664-05	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	10135-664-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	10135-664-05	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	10135-664-01	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	10135-664-05	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	10135-664-01	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	10135-664-05	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	10135-664-01	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	10135-664-05	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A208507-001	METHOCARBAMOL	METHOCARBAMOL	500MG	TABLET / ORAL	AA		2017-07-21
A208507-002	METHOCARBAMOL	METHOCARBAMOL	750MG	TABLET / ORAL	AA		2017-07-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A208507-001	AA
A208507-002	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A208507-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2017-07-21	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A208507-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2017-07-21	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A208507-001	AA	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208507-002	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208507-001	AA	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208507-002	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A208507-001	AA	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208507-002	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208507-001	AA	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208507-002	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208507-001	AA	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208507-002	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208507-001	AA	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208507-002	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208507-001	AA	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208507-002	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208507-001	AA	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208507-002	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208507-001	AA	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208507-002	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A208507-001	AA	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A208507-002	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208507-001	AA	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208507-002	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208507-001	AA	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208507-002	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208507-001	AA	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208507-002	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A208507-001	AA	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A208507-002	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208507-001	AA	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208507-002	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A208507-001	AA	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A208507-002	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A208507-001	AA	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A208507-002	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A208507-001	AA	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A208507-002	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A208507-001	AA	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A208507-002	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A208507-001	AA	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A208507-002	AA	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
492965be-47bc-38cf-57c4-5c5e0343abe5	Product name	6	20211028
3c386306-c48a-413e-bb69-70cb268496f3	Product name	1	20210727
02a01e9c-3f4e-c0ee-6542-be865127aea3	Product name	8	20190205

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
10135-664-01	2023-01-30	Methocarbamol Tablets
10135-664-05	2023-01-30	Methocarbamol Tablets
10135-664-01	2020-02-19	Methocarbamol Tablets
10135-664-50	2020-02-19	Methocarbamol Tablets
10135-664-01	2020-01-31	Methocarbamol Tablets
10135-664-50	2020-01-31	Methocarbamol Tablets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
10135-664-01	Methocarbamol	100 in 1 BOTTLE	TABLET, FILM COATED	100		4
10135-664-05	Methocarbamol	500 in 1 BOTTLE	TABLET, FILM COATED	500		4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
10135-664-01	EA - Each	10135-664	0674fac1-cec9-4e39-bd5d-b04bd33dee79	1	2018-11-06
10135-664-05	EA - Each	10135-664	6a80046a-b259-4698-b225-15a0d135b637	1	2020-03-10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10135-664	METHOCARBAMOL TABLET, FILM COATED [MARLEX PHARMACEUTICALS INC]	4	Legacy NDC, 2 package rows	20211205_01baa84f-453e-4954-bdf1-276ad7d484a1.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 15 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Methocarbamol	METHOCARBAMOL	Bryant Ranch Prepack	3212f121-9428-4186-8f00-accf08bca473	2026-05-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	PD-Rx Pharmaceuticals, Inc.	288a3bcd-a2c8-4a9b-9602-59c0493b4a8d	2026-02-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	PD-Rx Pharmaceuticals, Inc.	3b0e60a7-3cff-4665-a473-ad3257619cdd	2026-02-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	PD-Rx Pharmaceuticals, Inc.	943fe701-5d7d-4abe-a529-c5a548e94bc6	2026-02-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	PD-Rx Pharmaceuticals, Inc.	440bf1ba-a704-4c35-bece-0a0987fc0c11	2026-02-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	PD-Rx Pharmaceuticals, Inc.	12c8da39-3a0e-4303-9655-29dd83507837	2026-02-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	UNICHEM PHARMACEUTICALS (USA), INC.	5777cbb0-b5fd-4b36-ac1d-bc105fe96888	2026-01-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	A-S Medication Solutions	ff572473-90e3-4f3b-a40e-8b97b86d327b	2025-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	A-S Medication Solutions	9357672f-5d4d-40f5-a304-e0c34e174dc3	2025-06-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	Advanced Rx Pharmacy of Tennessee, LLC	c06c4a63-491c-baa2-e053-2a95a90a09ff	2024-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	Advanced Rx Pharmacy of Tennessee, LLC	c9600cc9-7e27-6e19-e053-2995a90ab024	2024-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	Asclemed USA, Inc.	c40d5c1d-9bd8-44aa-85a4-e1a34e1d3673	2022-10-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	Proficient Rx LP	201205d1-22f2-46bb-b298-02d4978ba568	2022-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	Proficient Rx LP	39b4362e-a26e-49cb-9d06-898bc9b0e005	2021-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507
Methocarbamol	METHOCARBAMOL	Aphena Pharma Solutions - Tennessee, LLC	d825e4d6-8b00-473a-a6e6-90f5c3ad5bec	2018-10-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208507 application number: ANDA208507

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
125OD7737X	METHOCARBAMOL	532-03-6	METHOCARBAMOL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197943	methocarbamol 500 MG Oral Tablet	PSN	01baa84f-453e-4954-bdf1-276ad7d484a1	4
197944	methocarbamol 750 MG Oral Tablet	PSN	01baa84f-453e-4954-bdf1-276ad7d484a1	4
197943	methocarbamol 500 MG Oral Tablet	SCD	01baa84f-453e-4954-bdf1-276ad7d484a1	4
197944	methocarbamol 750 MG Oral Tablet	SCD	01baa84f-453e-4954-bdf1-276ad7d484a1	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
10135-664-01	10135066401	100 TABLET, FILM COATED in 1 BOTTLE (10135-664-01)	2018-10-01	0000-00-00	No	No	Current
10135-664-05	10135066405	500 TABLET, FILM COATED in 1 BOTTLE (10135-664-05)	2018-10-01	0000-00-00	No	No	Current
10135-664-50	10135066450	500 TABLET, FILM COATED in 1 BOTTLE (10135-664-50)	2018-10-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Methocarbamol Tablets	Marlex Pharmaceuticals Inc	2021-12-04	HUMAN PRESCRIPTION DRUG LABEL	4
Methocarbamol Tablets	Aphena Pharma Solutions - Tennessee, LLC	2019-01-21	HUMAN PRESCRIPTION DRUG LABEL	1